69 results on '"Valentino, L. A."'
Search Results
2. Keeping Horror in Mind: Psychoanalysis and the 'New Direction' of EC Comics
3. Towards Catalytically Active Porous Graphene Membranes with Pulsed Laser Deposited Ceria Nanoparticles
4. Keeping Horror in Mind: Psychoanalysis and the “New Direction” of EC Comics
5. Towards Catalytically Active Porous Graphene Membranes with Pulsed Laser Deposited Ceria Nanoparticles
6. Validation of the Haemophilia & Exercise Project-Test-Questionnaire (HEP-Test-Q)-An instrument for the assessment of subjective physical functioning in children with haemophilia
7. Prophylactic bypassing agent use before and during immune tolerance induction in patients with haemophilia A and inhibitors toFVIII
8. Target plasma factor levels for personalized treatment in haemophilia: a Delphi consensus statement
9. Haemarthrosis model in mice: BSS - Bleeding Severity Score assessment system
10. Association of peak factor VIII levels and area under the curve with bleeding in patients with haemophilia A on every third day pharmacokinetic‐guided prophylaxis
11. Fully Vapor‐Deposited Heterostructured Light‐Emitting Diode Based on Organo‐Metal Halide Perovskite
12. Health‐related quality of life assessment in haemophilia patients on prophylaxis therapy: a systematic review of results from prospective clinical trials
13. Central venous access device (CVAD) complications in Haemophilia with inhibitors undergoing immune tolerance induction: Lessons from the international immune tolerance study
14. Should anti‐inhibitor coagulant complex and tranexamic acid be used concomitantly?
15. Utility of a Paediatric Bleeding Questionnaire as a screening tool for von Willebrand disease in apparently healthy children
16. Safety of radiation exposure after radiosynovectomy in paediatric patients with haemophilia
17. Neonatal circumcision in severe haemophilia: a survey of paediatric haematologists at United States Hemophilia Treatment Centers
18. The biological efficacy profile of BAX 855, a PEGylated recombinant factor VIII molecule
19. Matrix-assisted laser desorption/ionization (MALDI) imaging mass spectrometry (IMS): peering into the cup of Jamshid
20. Considerations in individualizing prophylaxis in patients with haemophilia A
21. ADVATE prophylaxis:post hocanalysis of joint bleeding episodes
22. Multicentre, randomized, open-label study of on-demand treatment with two prophylaxis regimens of recombinant coagulation factor IX in haemophilia B subjects
23. The first recombinant FVIII produced in human cells – an update on its clinical development programme
24. An ‘ice age’ concept? The use of ice in the treatment of acute haemarthrosis in haemophilia
25. Desmopressin (DDAVP) in the management of patients with congenital bleeding disorders
26. Towards personalizing haemophilia care: using the Haemophilia Severity Score to assess 178 patients in a single institution
27. Case studies in the management of refractory bleeding in patients with haemophilia A and inhibitors
28. Physician preferences for medication attributes for the prophylactic treatment of patients with severe haemophilia A with inhibitors to factor VIII
29. The effect of cooling on coagulation and haemostasis: Should “Ice” be part of treatment of acute haemarthrosis in haemophilia?
30. Multidisciplinary management of patients with haemophilia with inhibitors undergoing surgery in the United States: perspectives and best practices derived from experienced treatment centres
31. Pharmacokinetic properties of IB1001, an investigational recombinant factor IX, in patients with haemophilia B: repeat pharmacokinetic evaluation and sialylation analysis
32. Consequences of intra-articular bleeding in haemophilia: science to clinical practice and beyond
33. Patient- and caregiver-reported bleeding symptoms and reasons for starting and stopping treatment with recombinant factor VIIa: analysis of the Dosing Observational Study in Haemophilia (DOSE)
34. Healthcare resource utilization among haemophilia A patients in the United States
35. Exploring the biological basis of haemophilic joint disease: experimental studies
36. Joint protection in haemophilia
37. An uncommon cause of knee haemarthrosis in an adult haemophilia patient suffering from long‐term paraplegia
38. von Willebrand factor/factor VIII concentrate (Humate-P) for management of elective surgery in adults and children with von Willebrand disease
39. Surgical Experience with rFVIIa (NovoSeven) in congenital haemophilia A and B patients with inhibitors to factors VIII or IX
40. Postauthorization safety surveillance of ADVATE [antihaemophilic factor (recombinant), plasma/albumin‐free method] demonstrates efficacy, safety and low‐risk for immunogenicity in routine clinical practice
41. Assessment of blood-induced arthritis causes friction
42. Volvulus of the large colon in a foal
43. Assessing the benefits of FEIBA prophylaxis in haemophilia patients with inhibitors
44. Controversies regarding the prophylactic management of adults with severe haemophilia A
45. Factor VIII prophylaxis for adult patients with severe haemophilia A: results of a US survey of attitudes and practices
46. The application of bypassing-agent prophylaxis in haemophilia A patients with inhibitors: a meeting report
47. The benefits of prophylactic treatment with APCC in patients with haemophilia and high-titre inhibitors: a retrospective case series
48. Experience with a third generation recombinant factor VIII concentrate (Advate®) for immune tolerance induction in patients with haemophilia A
49. Prevention of haemarthrosis in a murine model of acute joint bleeding
50. Prophylaxis for severe haemophilia: clinical challenges in the absence as well as in the presence of inhibitors
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.